Filana Therapeutics Q3 EPS $(0.22) Beats $(0.24) Estimate
Benzinga Newsdesk 2 hours ago
NewsEarningsEarnings Beats
Filana Therapeutics (NASDAQ:FLNA) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.24) by 8.33 percent. This is unchanged from the same period last year.
Filana Therapeutics (NASDAQ:FLNA) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.24) by 8.33 percent. This is unchanged from the same period last year.